Back to Studies
P1115 / Very Early Intensive Tx on HIV-Infected Infants
Very Early Intensive Treatment of HIV-Infected Infants to Achieve HIV Remission: A Phase I/II Proof of Concept Study
Study Status
Enrolling
Locality
US & Non-US
DAIDS Number
11954
IND Number
Non-IND
Clinical Trials Link
Primary Protocol Team Members
Summary
P1115 is a Phase I/II, multi-center, proof-of-concept study that will explore the effects of early intensive antiretroviral therapy on achieving HIV remission in neonates. The study will also assess the safety and pharmacokinetics of early intensive antiretroviral therapy in neonates.
Loading study documents...
Loading study sites...
Loading study protocol team...
Loading study press...
Loading study publications/presentations...